Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine

Stopped This secondary data analysis of symptomatic CVS MinuteClinics patients testing for SARS-CoV-2 was terminated due to incomplete data on KP.2 vaccination status (exposure). Termination was not based on any safety concerns or regulatory requirements.

Conditions

• COVID-19

Interventions

• BIOLOGICAL: Pfizer-BioNTech BNT162b2 COVID-19 Vaccinated
• BIOLOGICAL: Not vaccinated with 2024-2025 formulated COVID-19 vaccine

Sponsor

Pfizer

Collaborators

• [object Object]